Cardinal Health reported strong second-quarter fiscal year 2026 results, with revenue rising 19% year over year to $65.6 billion. GAAP operating earnings increased 29% to $707 million, while GAAP diluted EPS grew 19% to $1.97. On a non-GAAP basis, operating earnings climbed 38% to $877 million and diluted EPS rose 36% to $2.63, supported by higher segment profits and a lower share count, partly offset by higher financing costs. Reflecting this performance, Cardinal Health raised its fiscal 2026 non-GAAP EPS guidance to a range of $10.15–$10.35, completed its annual $750 million baseline share repurchase, and reached its targeted leverage range.

Source: PRNewswire